Latest News about BIIB
Recent news which mentions BIIB
Better Alzheimer's Disease Stock: Eli Lilly or Biogen?
October 05, 2022
From Motley Fool
2 Signals to Watch Before Buying SAVA Stock
October 05, 2022
From InvestorPlace
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation
October 04, 2022
From Motley Fool
Vyant Bio Inc. (NASDAQ: VYNT): Leading a New Biotech Move to Combat Diseases Affecting the Nervous System
October 04, 2022
From Benzinga
From Benzinga
Is Eli Lilly Stock a Buy Following This Competitor's Major Win?
October 03, 2022
From Motley Fool
Tickers
BIIB
From Motley Fool
Why the Porsche IPO Generated So Much Excitement
October 01, 2022
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
September 29, 2022
From Benzinga
Is Biogen a Smart Biotech Stock to Buy Right Now?
September 29, 2022
From Motley Fool
Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday
September 29, 2022
From Benzinga
Netflix, Biogen And Other Big Gainers From Wednesday
September 29, 2022
From Benzinga
7 Growth Stocks to Buy to Tap Into a Hidden Bull Market
September 28, 2022
From InvestorPlace
Why Moderna Stock Lagged the Market Today
September 28, 2022
From Motley Fool
These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win
September 28, 2022
From Benzinga
Here's How Much $100 Invested In Biogen 20 Years Ago Would Be Worth Today
September 28, 2022
Tickers
BIIB
From Benzinga
Alphabet To $136? Plus This Analyst Slashes PT On United Natural Foods
September 28, 2022
From Benzinga
What The Biogen Chart Reveals As Stock Rallies Hard On Alzheimer's Data
September 28, 2022
Tickers
BIIB
From Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
September 28, 2022
From Benzinga
Biotech Stocks LLY, ESALY Gain on Biogen’s Positive Trial Results
September 28, 2022
From InvestorPlace
Why Is Prothena (PRTA) Stock Up 75% Today?
September 28, 2022
From InvestorPlace
Why Prothena Corporation Shares Are Trading Higher By 76%, Here Are 53 Stocks Moving In Wednesday's Mid-Day Session
September 28, 2022
From Benzinga
Why Is Acumen (ABOS) Stock Up 95% Today?
September 28, 2022
From InvestorPlace
This Analyst Believes Biogen's Lecanemab Data Not 'Slam Dunk' For Complete CMS Approval
September 28, 2022
From Benzinga
BMO Capital Upgrades Biogen: Here's What You Need To Know
September 28, 2022
Tickers
BIIB
From Benzinga
7 Biogen Analysts On Alzheimer's Drug Success As Stock Skyrockets 37%
September 28, 2022
Tickers
BIIB
From Benzinga
Why Biogen, Lilly, and Prothena Stocks Are Skyrocketing Today
September 28, 2022
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.